Safety and Effectiveness of Giving Indinavir Plus Stavudine Plus Lamivudine to HIV-Infected Children

The purpose of this study is to see if it is safe and effective to give an anti-HIV drug combination of indinavir (IDV) plus stavudine (d4T) plus lamivudine (3TC) to HIV-infected children. IDV will be given either as a powder mixed into applesauce or as capsules given on an empty stomach. In this multicenter, open-label study patients receive a combined drug regimen of indinavir, stavudine, and lamivudine over 48 weeks. Patients are evaluated at ... more

Medical trial

ClinicalTrials.gov Identifier:

  • NCT00000901

Type of trial:

Phase:

Expected total enrollment:

  • 24

Minimum age for eligibility:

  • 3

Maximum age for eligibility:

  • 15

Eligibility inclusion criteria:

  • Is HIV-positive.
  • Is generally healthy.
  • Is able to swallow medication in capsule form.
  • Has never taken d4T or has never taken 3TC.
  • # Is 3 - 15 years old and has consent of a parent or legal guardian who is able to return with the child for follow-up visits.
  • Agrees to use barrier methods of birth control (such as condoms) during the study. The pill is not allowed during the study.

Eligibility exclusion criteria:

  • Has a history of certain serious illnesses.
  • Is unable to take any of the medications in this study for any reason.
  • Has a history of severe diarrhea.
  • # Has a serious infection at the time of study entry.
  • Is pregnant or breast-feeding.
  • Has taken certain medications.
  • # Has taken any non-nucleoside reverse transcriptase inhibitors (NNRTIs), such as efavirenz (EFV), within 2 weeks prior to study entry.
  • Has taken any protease inhibitors (PIs).

Diseases:

top ↑
Edit and Show details

Add or delete facts, download data in JSON or RDF formats, and explore topic metadata.

Freebase Logo
What is Freebase?

Freebase is a huge collection of facts, built by people like you. Freebase connects facts in ways other sites can't, giving you new ways to explore millions of subjects.
You can help improve it!

Freebase Attribution

Freebase data is free for use under the CC-BY license.

Learn more about Freebase licensing and attribution